Acknowledgement
This work was supported by the National Research Foundation of Korea (NRF) under Grant (2018R1D1A1B07050160).
References
- Ahmed HU, El-Shater Bosaily A, Brown LC, Gabe R, Kaplan R, Parmar MK, et al. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet 2017;389:815-822 https://doi.org/10.1016/S0140-6736(16)32401-1
- Kasivisvanathan V, Rannikko AS, Borghi M, Panebianco V, Mynderse LA, Vaarala MH, et al. MRI-targeted or standard biopsy for prostate-cancer diagnosis. N Engl J Med 2018;378:1767-1777 https://doi.org/10.1056/NEJMoa1801993
- Baur ADJ, Hansen CM, Rogasch J, Posch H, Elezkurtaj S, Maxeiner A, et al. Evaluation of T1 relaxation time in prostate cancer and benign prostate tissue using a Modified Look-Locker inversion recovery sequence. Sci Rep 2020;10:3121
- Mai J, Abubrig M, Lehmann T, Hilbert T, Weiland E, Grimm MO, et al. T2 mapping in prostate cancer. Invest Radiol 2019;54:146-152 https://doi.org/10.1097/RLI.0000000000000520
- Chatterjee A, Devaraj A, Mathew M, Szasz T, Antic T, Karczmar GS, et al. Performance of T2 maps in the detection of prostate cancer. Acad Radiol 2019;26:15-21 https://doi.org/10.1016/j.acra.2018.04.005
- Foltz WD, Haider MA, Chung P, Bayley A, Catton C, Ramanan V, et al. Prostate T(1) quantification using a magnetization-prepared spiral technique. J Magn Reson Imaging 2011;33:474-481 https://doi.org/10.1002/jmri.22450
- Wu LM, Chen XX, Xuan HQ, Liu Q, Suo ST, Hu J, et al. Feasibility and preliminary experience of quantitative T2** mapping at 3.0 T for detection and assessment of aggressiveness of prostate cancer. Acad Radiol 2014;21:1020-1026 https://doi.org/10.1016/j.acra.2014.04.007
- Ma D, Gulani V, Seiberlich N, Liu K, Sunshine JL, Duerk JL, et al. Magnetic resonance fingerprinting. Nature 2013;495:187-192 https://doi.org/10.1038/nature11971
- van Houdt PJ, Agarwal HK, van Buuren LD, Heijmink SWTPJ, Haack S, van der Poel HG, et al. Performance of a fast and high-resolution multi-echo spin-echo sequence for prostate T2 mapping across multiple systems. Magn Reson Med 2018;79:1586-1594 https://doi.org/10.1002/mrm.26816
- Panda A, Obmann VC, Lo WC, Margevicius S, Jiang Y, Schluchter M, et al. MR fingerprinting and ADC mapping for characterization of lesions in the transition zone of the prostate gland. Radiology 2019;292:685-694 https://doi.org/10.1148/radiol.2019181705
- Panda A, O'Connor G, Lo WC, Jiang Y, Margevicius S, Schluchter M, et al. Targeted biopsy validation of peripheral zone prostate cancer characterization with MR fingerprinting and diffusion mapping. Invest Radiol 2019;54:485-493 https://doi.org/10.1097/RLI.0000000000000569
- Yu AC, Badve C, Ponsky LE, Pahwa S, Dastmalchian S, Rogers M, et al. Development of a combined MR fingerprinting and diffusion examination for prostate cancer. Radiology 2017;283:729-738 https://doi.org/10.1148/radiol.2017161599
- Shiradkar R, Panda A, Leo P, Janowczyk A, Farre X, Janaki N, et al. T1 and T2 MR fingerprinting measurements of prostate cancer and prostatitis correlate with deep learning-derived estimates of epithelium, lumen, and stromal composition on corresponding whole mount histopathology. Eur Radiol 2021;31:1336-1346 https://doi.org/10.1007/s00330-020-07214-9
- Ma D, Jones SE, Deshmane A, Sakaie K, Pierre EY, Larvie M, et al. Development of high-resolution 3D MR fingerprinting for detection and characterization of epileptic lesions. J Magn Reson Imaging 2019;49:1333-1346 https://doi.org/10.1002/jmri.26319
- Yushkevich PA, Piven J, Hazlett HC, Smith RG, Ho S, Gee JC, et al. User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability. Neuroimage 2006;31:1116-1128 https://doi.org/10.1016/j.neuroimage.2006.01.015
- Liu W, Turkbey B, Senegas J, Remmele S, Xu S, Kruecker J, et al. Accelerated T2 mapping for characterization of prostate cancer. Magn Reson Med 2011;65:1400-1406 https://doi.org/10.1002/mrm.22874
- Simpkin CJ, Morgan VA, Giles SL, Riches SF, Parker C, deSouza NM. Relationship between T2 relaxation and apparent diffusion coefficient in malignant and non-malignant prostate regions and the effect of peripheral zone fractional volume. Br J Radiol 2013;86:20120469
- Bojorquez JZ, Bricq S, Acquitter C, Brunotte F, Walker PM, Lalande A. What are normal relaxation times of tissues at 3 T? Magn Reson Imaging 2017;35:69-80 https://doi.org/10.1016/j.mri.2016.08.021
- Bojorquez JZ, Bricq S, Brunotte F, Walker PM, Lalande A. A novel alternative to classify tissues from T 1 and T 2 relaxation times for prostate MRI. MAGMA 2016;29:777-788 https://doi.org/10.1007/s10334-016-0562-3
- de Bazelaire CM, Duhamel GD, Rofsky NM, Alsop DC. MR imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0 T: preliminary results. Radiology 2004;230:652-659 https://doi.org/10.1148/radiol.2303021331